Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia
Meng-Jiao Lin, Shu-Bin Zou, Bai-Xiang Zhu, Three departments of cardiovascular medicine, Harbin 242 Hospital, Harbin 150066, Heilongjiang Province, China
Co-first authors: Meng-Jiao Lin and Shu-Bin Zou.
Author contributions: Lin MJ and Zou SB proposed the concept of this study, jointly wrote the first draft; Zhu BX validated this study, contributed to data collection; Lin MJ contributed to formal analysis; Zhu BX and Lin MJ participated in the survey; Zou SB and Zhu BX contributed to the methods; Lin MJ contributed to the visualization of this study. All authors collectively guided the research, reviewed, and edited the manuscript.
Supported by General Medical Research Fund Project, No. TYYLKYJJ-2022-025.
Institutional review board statement: This study has been reviewed and approved by the Ethics Committee of Harbin 242 Hospital.
Clinical trial registration statement: This study is registered at the Clinical Registry.
https://www.researchregistry.com (Reviewreg1890). Uploaded a separate file as the registration certificate.
Informed consent statement: This study has obtained the consent of patients and guardians and signed an informed consent form.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Bai-Xiang Zhu, MM, Chief physician, Department of Cardiovascular, Harbin 242 Hospital, No. 3 Weijian Street, Pingfang District, Harbin 150066, Heilongjiang Province, China. farc364@163.com
Received: February 21, 2024
Revised: April 9, 2024
Accepted: April 18, 2024
Published online: June 26, 2024
Processing time: 118 Days and 0.1 Hours
